Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.

NCT01227811 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Bioequivalency

Interventions

DRUG: Darifenacin
DRUG: Darifenacin

Sponsor

Center for Clinical Pharmacology Research Bdbeq S.A.

Collaborators

[object Object]